Amarin Corp Plc (AMRN)

[KCSVEN]

Would depend on the details. I believe the science indicates Reduce IT will be successful. Since Angina is on the list of endpoints I think its near impossible for it not to successfully meet that endpoint and thus call it a success.

Whether it effects the other endpoints is less clear to me though I think the science says it will. But it does not matter, It's overall events and overall, just solely on the Angina, it should be a success.

So with that thought I am likely to want to reap some reward when that hits and sales jump. Since the money tied up in AMRN is easy to hold long term I'd have no qualms with CVR if the terms were reasonable.